Access individual 2019 reporting measures for MIPS by clicking the links in the table below. You can also access information on 2020 reporting measures.
|MIPS 138||Melanoma: Coordination of Care|
Percentage of patients with a new occurrence of melanoma who have their melanoma treatment plan sent to the physician providing continuity of care.
|MIPS 137||Melanoma: Continuity of Care – Recall System||Percentage of patients with melanoma who have their information entered into a recall system.|
|MIPS 265||Biopsy Follow-up|
Percentage of patients who have biopsy results sent to another physician.
|MIPS 337||Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier|
Percentage of patients who are screened for TB when they have psoriasis, psoriatic arthritis, or rheumatoid arthritis and are also on a biological immune response modifier.
|MIPS 410||Psoriasis: Clinical Response to Systemic Medications|
Percentage of patients receiving systematic medication who meet minimal physician or patient-reported disease activity levels.
|MIPS 440||Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time – Pathologist to Clinician|
Percentage of biopsies in which the results are sent back to the clinician within seven days.
|MIPS 46||Medication Reconciliation Post-Discharge|
Percentage of patients who are discharged from an inpatient facility and have their discharge medication list reconciled with the current medication list.
|MIPS 47||Advance Care Plan||Percentage of patients aged 65 or older who have been counseled on creating an advance care plan.|
|MIPS 110||Preventive Care and Screening: Influenza Immunization|
Percentage of patients who have received an influenza vaccine during flu season.
|MIPS 111||Pneumococcal Vaccination Status for Older Adults|
Percentage of patients aged 65 or older who receive pneumococcal vaccination.
|MIPS 128||Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan|
Percentage of patients aged 18 or older who have BMI measured, and when BMI is outside of normal parameters, receive a follow-up plan.
|MIPS 130||Documentation of Current Medications in the Medical Record|
Percentage of patients who have a comprehensive current medication list.
|MIPS 131||Pain Assessment and Follow-Up|
Percentage of patients who have their pain evaluated, and when pain is present, receive a follow-up plan.
|MIPS 431||Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling|
Percentage of adult patients screened for unhealthy alcohol use, and when unhealthy use is present, receive brief counseling.
|MIPS 317||Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented|
Percentage of patients who are screened for high blood pressure, and when high blood pressure is present, receive a follow-up plan.
|MIPS 205||HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis|
Percentage of patients aged 13 years or older with a diagnosis of HIV/AIDS who are screened for chlamydia, gonorrhea, and syphilis.
|MIPS 226||Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention|
Percentage of adult patients who are screened for tobacco use, and if identified as a tobacco user, receive tobacco cessation intervention.
|MIPS 358||Patient-Centered Surgical Risk Assessment and Communication|
Percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed by their surgical team prior to surgery and who discussed those risks with the surgeon.
|MIPS 397||Melanoma Reporting|
Percentage of pathology reports for primary malignant cutaneous melanoma that include the pT category and a statement on thickness, ulceration, and mitotic rate.
|MIPS 402||Tobacco Use and Help with Quitting Among Adolescents|
Percentage of adolescents that are screened for tobacco use, and if identified as a tobacco user, receive tobacco cessation intervention.
|MIPS 374||Closing the Referral Loop: Receipt of Specialist Report|
Percentage of patients who are referred and the referring provider receives a report from the other provider.
Access individual reporting measures for QCDR by clicking the links in the table below.
|Measure||Measure name||Measure description|
|Psoriasis: Screening for Psoriatic Arthritis|
Percentage of patients with a diagnosis of psoriasis who are screened for psoriatic arthritis.
|AAD 5||Biopsy: Reporting Time - Clinician to Patient|
Percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal or squamous cell carcinoma (including in situ disease) who are notified of their final biopsy pathology findings within 14 days.
|ACMS 1 |
|Adherence to Mohs Micrographic Surgery Appropriate Use Criteria|
Percentage of Mohs micrographic surgery cases that meet criteria according to published Mohs surgery appropriate use criteria (AUC) guidelines.
This table shows measures that are topped out.
|Topped out for MIPS reporting||Topped out for registry reporting|
|Measure 265||Measure 130|
|Measure 440||Measure AAD2|
|Measure 46||Measure AAD5|
|Measure 128 (for claims)|
|Measure 130 (for claims)|
|Measure 131 (for claims)|